MXPA04007918A - Derivados de fenalenona, procedimientos para su preparacion y utilizacion de los mismos. - Google Patents

Derivados de fenalenona, procedimientos para su preparacion y utilizacion de los mismos.

Info

Publication number
MXPA04007918A
MXPA04007918A MXPA04007918A MXPA04007918A MXPA04007918A MX PA04007918 A MXPA04007918 A MX PA04007918A MX PA04007918 A MXPA04007918 A MX PA04007918A MX PA04007918 A MXPA04007918 A MX PA04007918A MX PA04007918 A MXPA04007918 A MX PA04007918A
Authority
MX
Mexico
Prior art keywords
formula
compound
alkyl
preparation
alkenyl
Prior art date
Application number
MXPA04007918A
Other languages
English (en)
Spanish (es)
Inventor
Li Ziyu
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of MXPA04007918A publication Critical patent/MXPA04007918A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/92—Naphthofurans; Hydrogenated naphthofurans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungi isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/04—Oxygen as only ring hetero atoms containing a five-membered hetero ring, e.g. griseofulvin, vitamin C
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/22—Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/80—Penicillium

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Furan Compounds (AREA)
MXPA04007918A 2002-02-18 2003-02-04 Derivados de fenalenona, procedimientos para su preparacion y utilizacion de los mismos. MXPA04007918A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10206849A DE10206849A1 (de) 2002-02-18 2002-02-18 Phenalenon-Derivate, Verfahren zur Herstellung und Verwendung derselben
PCT/EP2003/001060 WO2003068946A1 (de) 2002-02-18 2003-02-04 Phenalenon-derivative, verfahren zur herstellung und verwendung derselben

Publications (1)

Publication Number Publication Date
MXPA04007918A true MXPA04007918A (es) 2004-11-26

Family

ID=27674733

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04007918A MXPA04007918A (es) 2002-02-18 2003-02-04 Derivados de fenalenona, procedimientos para su preparacion y utilizacion de los mismos.

Country Status (10)

Country Link
EP (1) EP1478731A1 (enExample)
JP (1) JP2005517710A (enExample)
AR (1) AR038524A1 (enExample)
AU (1) AU2003210205B2 (enExample)
BR (1) BR0307733A (enExample)
CA (1) CA2476618A1 (enExample)
DE (1) DE10206849A1 (enExample)
MX (1) MXPA04007918A (enExample)
PE (1) PE20030904A1 (enExample)
WO (1) WO2003068946A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010113725A1 (ja) * 2009-03-30 2010-10-07 日本水産株式会社 三環性縮合複素環化合物、その製造方法および用途
WO2011009899A2 (en) * 2009-07-22 2011-01-27 Instituto Biomar, S.A. Phenalenones as antitumoral agents
FR2987622B1 (fr) * 2012-03-02 2016-01-15 Centre Nat Rech Scient Composes oxo-phenalenes, leur preparation et utilisation dans les domaines des materiaux et therapeutique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2812510B2 (ja) * 1989-10-06 1998-10-22 日清製油株式会社 アトロベネチンの用途
EP1151295A4 (en) * 1999-02-01 2005-03-30 Cytovia Inc METHOD FOR IDENTIFYING THERAPEUTICALLY EFFECTIVE ANTINEOPLASTIC SUBSTANCES USING CULTURED CELLS WITH INTACT CELL MEMBRANES AND RELATED PRODUCTS THEREOF

Also Published As

Publication number Publication date
DE10206849A1 (de) 2005-07-28
JP2005517710A (ja) 2005-06-16
EP1478731A1 (de) 2004-11-24
AR038524A1 (es) 2005-01-19
WO2003068946A1 (de) 2003-08-21
PE20030904A1 (es) 2003-11-18
CA2476618A1 (en) 2003-08-21
AU2003210205B2 (en) 2007-06-14
AU2003210205A1 (en) 2003-09-04
BR0307733A (pt) 2005-01-25

Similar Documents

Publication Publication Date Title
IE910935A1 (en) Antihypercholesterolemics
US5420157A (en) Inhibitors of farnesyl protein transferase or prodrugs thereof
AU2003210205B2 (en) Phenalenone derivatives, method for the production thereof and use of the same
US7253206B2 (en) Phenalenone derivatives, processes for preparation and use thereof
CA1230567A (en) Cl-1957a antibiotic compound and its production
US5322854A (en) Reveromycin A, method for preparing the same, and antitumor agent and antifungal agent comprising the same
US4771070A (en) CL-1957A antibiotic compound
EP0582267B1 (en) Substances and microorganisms which produce them
JP5170608B2 (ja) アフラトキシン生産阻害剤、及びそれを用いたアフラトキシン汚染防除方法
US5233062A (en) Antibiotic eicosenoic acids
JPH01112988A (ja) 新規物質ｄｃ―１０７
US5334613A (en) Antibacterial substance BE-24566B
US4847284A (en) Antifungal fermentation product and derivatives and compositions thereof
US5079376A (en) Novel substance uct-1003 and process for producing the same
GB2261374A (en) Inhibitors of farnesyl protein transferase as anti-cancer agents
WO2010012381A1 (en) Streptospirole derivatives
WO1994008940A1 (en) Acyclic tricarboxylic acid compounds
JPH05155888A (ja) 新規な抗生物質およびそれらの製造
JPH0515385A (ja) 新規な抗生物質アリサマイシンおよびその製法
CA2008628C (en) Substance uct-1003 and process for producing the same
WO1991008222A1 (en) Physiologically active substance be-16627
US20100063150A1 (en) Aflatoxin Production Inhibitor and Method for Controlling Aflatoxin Contamination Using the Same
WO2002026744A1 (en) Mpc1001 derivatives
MXPA04012309A (es) Derivados de acidos polienocarboxilicos, metodo para su produccion y el uso de los mismos.
JPH1149796A (ja) シクロエルゴスタン誘導体

Legal Events

Date Code Title Description
HC Change of company name or juridical status